BCL2 and neuroblastoma: Functional assays such as mitochondrial BH3 profiling, co-IP and more recently dynamic BH3 profiling can be performed on very small amounts of solid tumor tissue to successfully characterize Bcl-2 dependence patterns leading to apoptosis resistance in chemotherapy refractory solid tumors like NB and others [17, 19, 22].